Cart
sales@molnova.com
WAY-309060
CAS No. 309951-18-6
WAY-309060( —— )
Catalog No. M28814 CAS No. 309951-18-6
WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 39 | In Stock |
|
| 25MG | 79 | In Stock |
|
| 50MG | 128 | In Stock |
|
| 100MG | 210 | In Stock |
|
| 200MG | 300 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-309060
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
-
DescriptionWAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number309951-18-6
-
Formula Weight262.26
-
Molecular FormulaC13H14N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (381.30 mM)
-
SMILESCc1cc(NC(c(cc2)cc(OC)c2OC)=O)no1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.LEXICON PHARMACEUTICALS INC - US2012/65200, 2012, A1
molnova catalog
related products
-
PROTAC BRD4 ligand-1
PROTAC BRD4 ligand-1, a component of Protac GNE-987, is a ligand for BRD4 and acts as an inhibitor of BET.
-
SGC-SMARCA-BRDVIII
SGC-SMARCA-BRDVIII is a potent and selective inhibitor of SMARCA2, SMARCA4, PB1(2), PB1(3) and PB1(5) with Kds of 35 nM, 36 nM, 3.7 μM, 2.0 μM and 13 nM, respectively.
-
GSK620
GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.
